These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of warfarin and aspirin in secondary prevention of stroke. Elkind MS Curr Cardiol Rep; 2004 Mar; 6(2):135-42. PubMed ID: 14759359 [TBL] [Abstract][Full Text] [Related]
3. [Anticoagulation and antiaggregation in neurological patients]. Arnold M; Nedeltchev K; Mattle HP Ther Umsch; 2003 Jan; 60(1):33-5. PubMed ID: 12638476 [TBL] [Abstract][Full Text] [Related]
4. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease. Thompson PL; Verheugt FW Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549 [TBL] [Abstract][Full Text] [Related]
5. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials. Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538 [TBL] [Abstract][Full Text] [Related]
9. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL; Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy and anticoagulation in patients with hypertension. Griffin G Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617 [TBL] [Abstract][Full Text] [Related]
11. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation. Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888 [TBL] [Abstract][Full Text] [Related]
12. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study. Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342 [TBL] [Abstract][Full Text] [Related]
13. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Segal JB; McNamara RL; Miller MR; Powe NR; Goodman SN; Robinson KA; Bass EB Cochrane Database Syst Rev; 2001; (1):CD001938. PubMed ID: 11279741 [TBL] [Abstract][Full Text] [Related]